Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro R Chade

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Kidney360|August 8, 2025
RENAL SINGLE-NUCLEAR TRANSCRIPTOMICS IDENTIFIES NOVEL THERAPEUTIC TARGETS IN A PRECLINICAL MODEL OF CHRONIC KIDNEY DISEASEAlejandro R Chade, Sathesh K Sivasankaran, Rhys Sitz, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2006
Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemiaAlejandro R Chade, James D Krier, Stephen C Textor, et al.
American Journal of Hypertension|February 1, 2003
Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemiaAlejandro R Chade, Martin Rodriguez-Porcel, Steven J Rippentrop, et al.
Journal of Diabetes and Its Complications|September 3, 2013
C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic ratElizabeth R Flynn, Jonathan Lee, Zachary M Hutchens, et al.
Journal of the American Society of Nephrology : JASN|November 7, 2015
Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor ConstructAlejandro R Chade, Nathan A Tullos, Taylor W Harvey, et al.
American Journal of Physiology. Renal Physiology|June 16, 2020
Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-κB improves renal recovery in chronic kidney diseaseAlejandro R Chade, Maxx L Williams, Jason E Engel, et al.
Hypertension (Dallas, Tex. : 1979)|September 24, 2019
Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage PolarizationJason E Engel, Erika Williams, Maxx L Williams, et al.
Scientific Reports|March 19, 2021
A dose-escalating toxicology study of the candidate biologic ELP-VEGFJamarius P Waller, Stephen P Burke, Jason Engel, et al.
American Journal of Physiology. Renal Physiology|August 16, 2021
Intrarenal modulation of NF-κB activity attenuates cardiac injury in a swine model of CKD: a renal-cardio axisAlejandro R Chade, Jason E Engel, Michael E Hall, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemiaAlejandro R Chade, Xiangyang Zhu, Oren P Mushin, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Kidney360|August 8, 2025
RENAL SINGLE-NUCLEAR TRANSCRIPTOMICS IDENTIFIES NOVEL THERAPEUTIC TARGETS IN A PRECLINICAL MODEL OF CHRONIC KIDNEY DISEASEAlejandro R Chade, Sathesh K Sivasankaran, Rhys Sitz, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2006
Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemiaAlejandro R Chade, James D Krier, Stephen C Textor, et al.
American Journal of Hypertension|February 1, 2003
Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemiaAlejandro R Chade, Martin Rodriguez-Porcel, Steven J Rippentrop, et al.
Journal of Diabetes and Its Complications|September 3, 2013
C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic ratElizabeth R Flynn, Jonathan Lee, Zachary M Hutchens, et al.
Journal of the American Society of Nephrology : JASN|November 7, 2015
Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor ConstructAlejandro R Chade, Nathan A Tullos, Taylor W Harvey, et al.
American Journal of Physiology. Renal Physiology|June 16, 2020
Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-κB improves renal recovery in chronic kidney diseaseAlejandro R Chade, Maxx L Williams, Jason E Engel, et al.
Hypertension (Dallas, Tex. : 1979)|September 24, 2019
Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage PolarizationJason E Engel, Erika Williams, Maxx L Williams, et al.
Scientific Reports|March 19, 2021
A dose-escalating toxicology study of the candidate biologic ELP-VEGFJamarius P Waller, Stephen P Burke, Jason Engel, et al.
American Journal of Physiology. Renal Physiology|August 16, 2021
Intrarenal modulation of NF-κB activity attenuates cardiac injury in a swine model of CKD: a renal-cardio axisAlejandro R Chade, Jason E Engel, Michael E Hall, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemiaAlejandro R Chade, Xiangyang Zhu, Oren P Mushin, et al.
Pageof 11